Published in Vaccine Weekly, February 27th, 1995
Researcher Karl A. Brokstad and colleagues previously observed a similar trend, but the high level of influenza virus-specific antibody-secreting cells (ASC) in peripheral blood was short-lived and after two to three weeks returned to prevaccination...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly